Literature DB >> 22204862

Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.

Sara Elsøe1, Josefin Ahnström, Christina Christoffersen, Andrew N Hoofnagle, Peter Plomgaard, Jay W Heinecke, Christoph J Binder, Harry Björkbacka, Björn Dahlbäck, Lars B Nielsen.   

Abstract

OBJECTIVE: Oxidation of LDL plays a key role in the development of atherosclerosis. HDL may, in part, protect against atherosclerosis by inhibiting LDL oxidation. Overexpression of HDL-associated apolipoprotein M (apoM) protects mice against atherosclerosis through a not yet clarified mechanism. Being a lipocalin, apoM contains a binding pocket for small lipophilic molecules. Here, we report that apoM likely serves as an antioxidant in HDL by binding oxidized phospholipids, thus enhancing the antioxidant potential of HDL. METHODS AND
RESULTS: HDL was isolated from wild type mice, apoM-deficient mice, and two lines of apoM-Tg mice with ∼2-fold and ∼10-fold increased plasma apoM, respectively. Increasing amounts of HDL-associated apoM were associated with an increase in the resistance of HDL to oxidation with Cu(2+) or 2,2'-azobis 2-methyl-propanimidamide, dihydrochloride (AAPH) and to an increased ability of HDL to protect human LDL against oxidation. Oxidized phospholipids, but not native phospholipids, quenched the intrinsic fluorescence of recombinant human apoM and the quenching could be competed with myristic acid suggesting selective binding of oxidized phospholipid in the lipocalin-binding pocket of apoM.
CONCLUSIONS: The results suggest that apoM can bind oxidized phospholipids and that it increases the antioxidant effect of HDL. This new mechanism may explain at least part of the antiatherogenic potential of apoM. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22204862     DOI: 10.1016/j.atherosclerosis.2011.11.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  36 in total

1.  Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus.

Authors:  Mingxia Liu; Cecilia Frej; Carl D Langefeld; Jasmin Divers; Donald W Bowden; J Jeffrey Carr; Abraham K Gebre; Jianzhao Xu; Benny Larsson; Björn Dahlbäck; Barry I Freedman; John S Parks
Journal:  J Lipid Res       Date:  2019-05-27       Impact factor: 5.922

2.  Protein unfolding allows use of commercial antibodies in an apolipoprotein M sandwich ELISA.

Authors:  Markus Høybye Bosteen; Björn Dahlbäck; Lars Bo Nielsen; Christina Christoffersen
Journal:  J Lipid Res       Date:  2015-01-05       Impact factor: 5.922

Review 3.  Speciated High-Density Lipoprotein Biogenesis and Functionality.

Authors:  C Rosales; W S Davidson; B K Gillard; A M Gotto; H J Pownall
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

4.  Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.

Authors:  Mingxia Liu; Jeremy Allegood; Xuewei Zhu; Jeongmin Seo; Abraham K Gebre; Elena Boudyguina; Dongmei Cheng; Chia-Chi Chuang; Gregory S Shelness; Sarah Spiegel; John S Parks
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

5.  Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.

Authors:  Mingxia Liu; Jeongmin Seo; Jeremy Allegood; Xin Bi; Xuewei Zhu; Elena Boudyguina; Abraham K Gebre; Dorit Avni; Dharika Shah; Mary G Sorci-Thomas; Michael J Thomas; Gregory S Shelness; Sarah Spiegel; John S Parks
Journal:  J Biol Chem       Date:  2013-12-06       Impact factor: 5.157

Review 6.  HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.

Authors:  C R Sirtori; M Ruscica; L Calabresi; G Chiesa; R Giovannoni; J J Badimon
Journal:  Ann Med       Date:  2019 Nov - Dec       Impact factor: 4.709

7.  HDL and Oxidation.

Authors:  Qi Zhang; Zongzhe Jiang; Yong Xu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 8.  High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Georgette M Buga; Greg Hough; Alan C Wagner; Alan M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

9.  ApoM Suppresses TNF-α-Induced Expression of ICAM-1 and VCAM-1 Through Inhibiting the Activity of NF-κB.

Authors:  Ji-Juan Gao; Yan-Wei Hu; Yan-Chao Wang; Yan-Hua Sha; Xin Ma; Shu-Fen Li; Jia-Yi Zhao; Jing-Bo Lu; Chuan Huang; Jing-Jing Zhao; Lei Zheng; Qian Wang
Journal:  DNA Cell Biol       Date:  2015-06-09       Impact factor: 3.311

10.  Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure.

Authors:  Julio A Chirinos; Lei Zhao; Yi Jia; Cecilia Frej; Luigi Adamo; Douglas Mann; Swapnil V Shewale; John S Millar; Daniel J Rader; Benjamin French; Jeff Brandimarto; Kenneth B Margulies; John S Parks; Zhaoqing Wang; Dietmar A Seiffert; James Fang; Nancy Sweitzer; Christina Chistoffersen; Björn Dahlbäck; Bruce D Car; David A Gordon; Thomas P Cappola; Ali Javaheri
Journal:  Circulation       Date:  2020-04-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.